IMMX

Immix Biopharma (IMMX)

About Immix Biopharma (IMMX)

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Details

Daily high

$5.88

Daily low

$5.50

Price at open

$5.70

52 Week High

$7.73

52 Week Low

$1.34

Market cap

302.5M

Dividend yield

0.00%

Volume

341,895

Avg. volume

1.5M

P/E ratio

-7.30

Immix Biopharma News